Skip to main content
. 2019 Jun 26;27(4):906–914. doi: 10.1016/j.jfda.2019.06.001

Fig. 2.

Fig. 2

MRM chromatograms of each cardiovascular drug (black line) at LLOQ overlayed with blank (red line)analyzed by optimized DBS samplingmethods: (A) amlodipine (B) atenolol (C) atorvastatin (D) digoxin (E) enalapril (F) fenofibrate (G) furosemide (H) losartan (I) nifedipine (J) propranolol (K) simvastatin and (L) valsartan.